Cudworth A G, Barber H E
Eur J Pharmacol. 1975 Mar;31(1):23-8. doi: 10.1016/0014-2999(75)90074-6.
Following i.v. injection of glucose to rats, blood was collected from the carotid artery and the portal vein, and insulin was determined by radioimmunoassay. Pancreatic insulin release and hepatic insulin extraction were increased following the administration of glucocorticoid drugs and reduced following phenytoin. Hepatic glutathione-insulin transhydrogenase activity (GITA) was measured in each animal and found to be increased after glucocorticoid therapy but unaffected by phenytoin. In alloxan-diabetic rats, GITA was significantly increased following treatment with both methylprednisolone and phenytoin compared with control alloxan-diabetic rats. This is suggestive evidence that both these drugs can initiate an increase in GITA. It is concluded that the markedly raised GITA in steroid-treated non-diabetic rats is the combined result of a drug-induced effect plus the major inducing effect of an increased hepatic uptake of insulin on insulin degradation, whereas the main effect of phenytoin is a reduction of pancreatic insulin release.
给大鼠静脉注射葡萄糖后,从颈动脉和门静脉采集血液,并用放射免疫分析法测定胰岛素。给予糖皮质激素药物后,胰腺胰岛素释放和肝脏胰岛素提取增加,而苯妥英钠给药后则减少。测量每只动物的肝脏谷胱甘肽 - 胰岛素转氢酶活性(GITA),发现糖皮质激素治疗后该活性增加,但不受苯妥英钠影响。在四氧嘧啶糖尿病大鼠中,与对照四氧嘧啶糖尿病大鼠相比,甲基强的松龙和苯妥英钠治疗后GITA均显著增加。这提示证据表明这两种药物均可引发GITA升高。得出的结论是,在类固醇治疗的非糖尿病大鼠中,显著升高的GITA是药物诱导作用加上肝脏胰岛素摄取增加对胰岛素降解的主要诱导作用的综合结果,而苯妥英钠的主要作用是减少胰腺胰岛素释放。